Quick Answer
Xenon Pharmaceuticals Inc. reported Revenue (ASC 606) of $311.0 thousand for fiscal year 2017.
Xenon Pharmaceuticals Inc. Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2017 | $311.0K | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2017 | $264.0K | — | — |
- The most recent figure is from Xenon Pharmaceuticals Inc.’s fiscal year 2018 report (Form 10-K), filed with the SEC on March 6, 2019.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: